HUB:ASXHUB24 Limited Analysis
Data as of 2026-03-11 - not real-time
A$87.34
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
HUB24 Limited is currently trading below its short‑term moving averages, with the price sitting beneath the 20‑day and 50‑day SMA, and the MACD line remains in a bearish configuration. The RSI is in the low‑forties, indicating limited upward momentum, while volume has been on a downtrend, reinforcing the bearish technical backdrop. Valuation metrics are stretched: the price‑to‑earnings multiple is well above the industry average and the market price exceeds the discounted cash‑flow fair value estimate, suggesting the stock is overvalued at present.
On the fundamentals side, the company delivers exceptional profitability, boasting gross margins near 94% and operating margins close to 30%, alongside robust revenue growth of over 25% year‑over‑year. Return on equity is healthy, and the dividend payout ratio under 50% supports dividend sustainability. However, the high beta and elevated 30‑day volatility point to pronounced price swings, and the bearish technical signals temper short‑term optimism despite the strong underlying business.
On the fundamentals side, the company delivers exceptional profitability, boasting gross margins near 94% and operating margins close to 30%, alongside robust revenue growth of over 25% year‑over‑year. Return on equity is healthy, and the dividend payout ratio under 50% supports dividend sustainability. However, the high beta and elevated 30‑day volatility point to pronounced price swings, and the bearish technical signals temper short‑term optimism despite the strong underlying business.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below key moving averages
- bearish MACD and weakening volume
- valuation gap between market price and DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- strong revenue growth and high profitability margins
- sustainable dividend with moderate payout ratio
- persistent overvaluation but improving earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- high gross and operating margins indicating durable competitive advantage
- solid ROE and cash generation supporting long‑term cash flow
- potential for price correction aligning market price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth26.20%
Profit Margin23.39%
P/E Ratio68.2
ROE19.73%
ROA15.82%
Debt/Equity11.45
P/B Ratio13.1
Op. Cash FlowA$160.6M
Industry P/E17.2
Technical Analysis
TrendBearish
RSI42.2
SupportA$74.92
ResistanceA$104.21
MA 20A$90.56
MA 50A$93.51
MA 200A$99.15
MACDBearish
VolumeDecreasing
Fear & Greed Index76.5
Valuation
Fair ValueA$52.45
Target PriceA$109.52
Upside/Downside25.40%
GradeOvervalued
TypeGrowth
Dividend Yield0.82%
Risk Assessment
Beta1.18
Volatility73.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.